Booster Immunization

The FDA said children aged 6 months to 4 years who completed a three-dose series of Pfizer-BioNTech’s monovalent COVID-19 vaccine can now receive the company’s bivalent booster under an expanded emergency use authorization.

  Healio spoke with Debra Langlois, MD, pediatrician and clinical assistant professor at University of Michigan C.S. Mott Children’s Hospital, about everything providers need to know about COVID-19 vaccination for children.

  Healio spoke with Debra Langlois, MD, pediatrician and clinical assistant professor at University of Michigan C.S. Mott Children’s Hospital, about everything providers need to know about COVID-19 vaccination for children.

  Healio spoke with Debra Langlois, MD, pediatrician and clinical assistant professor at University of Michigan C.S. Mott Children’s Hospital, about everything providers need to know about COVID-19 vaccination for children.

  Healio spoke with Debra Langlois, MD, pediatrician and clinical assistant professor at University of Michigan C.S. Mott Children’s Hospital, about everything providers need to know about COVID-19 vaccination for children.

  Healio spoke with Debra Langlois, MD, pediatrician and clinical assistant professor at University of Michigan C.S. Mott Children’s Hospital, about everything providers need to know about COVID-19 vaccination for children.

The CDC for the first time has estimated how effective the bivalent COVID-19 vaccines have been against the newest dominant omicron subvariant of SARS-CoV-2.

A survey of U.S. adults who are vaccinated against COVID-19 found that many of them have not received a bivalent booster shot because they either do not know they are eligible for one or are unaware the shots exist.

Health officials said a safety signal detected by a national surveillance system is “very unlikely” to represent a “true clinical risk” for stroke among older people who received the Pfizer-BioNTech bivalent COVID-19 booster.

Protection against the omicron variant from the Pfizer-BioNTech COVID-19 vaccine waned after 3 months in children aged 5 to 11 years but was restored by a booster shot, according to study findings published in JAMA Network Open.